首页> 外国专利> pharmaceutical composition, methods for inducing or promoting t-cell activation, for inducing or promoting an immune response, for treating cancer and for treating an infection.

pharmaceutical composition, methods for inducing or promoting t-cell activation, for inducing or promoting an immune response, for treating cancer and for treating an infection.

机译:药物组合物,用于诱导或促进t细胞活化,用于诱导或促进免疫应答,用于治疗癌症和用于治疗感染的方法。

摘要

Several compounds have been found that modulate signal transduction through the pd-1 receptor. In some embodiments, the compounds promote or induce an activation signal through the pd-1 receptor that activates a t cell. The compounds may bind to pd-1 and inhibit or prevent ligands from binding to pd-1 and thus suppress inhibitory signal transduction through the pd-1 receptor.
机译:已发现几种化合物可调节通过pd-1受体的信号转导。在一些实施方案中,化合物通过激活t细胞的pd-1受体促进或诱导激活信号。所述化合物可以与pd-1结合并且抑制或防止配体与pd-1结合,从而抑制通过pd-1受体的抑制性信号转导。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号